Atea Pharmaceuticals

AVIRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$435.512 M

$5.43 +1.88%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$158.0M

Loss-making

Shares outstanding

80,204,699

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#211VogenxVOGX$438.2M
#212Prothena Corp PublicPRTA$436.9M
#213Atea PharmaceuticalsAVIR$435.5M
#214Opus GeneticsIRD$434.3M
#215ARS PharmaceuticalsSPRY$432.6M

What if Atea Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$377,459.86

Per share 69,514× higher

Bitcoin $1.72T

$21,442.68

Per share 3,949× higher

Nvidia $5.48T

$68,323.40

Per share 12,583× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Atea Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.